ClinicalTrials.Veeva

Menu

Immediate Mobilization After Cardiac Catheterisation (SAMOVAR)

Rigshospitalet logo

Rigshospitalet

Status

Unknown

Conditions

Vascular Access Complication
Comfort

Treatments

Other: Two hours bedrest
Other: Immediate mobilization

Study type

Interventional

Funder types

Other

Identifiers

NCT02069275
SAMOVAR 01

Details and patient eligibility

About

The purpose of this study is to investigate the frequency of bleeding and haematomas in patients undergoing coronary angiography or percutaneous coronary intervention via femoral artery and mobilized immediately after the procedure, compared to those mobilized after two hours (following the standard regimen). At the same time the investigators will investigate whether it reduces the discomfort being mobilized immediately after the procedure.

Full description

The frequency of hematoma, bleeding or pseudoaneurysm at the access site in the groin is 7-15% with regimens that involve 0-2 hours of bed rest, somewhat more frequent after Percutaneous coronary intervention (PCI) than coronary angiography (CAG). There seems to be no reduction in the complications of the CAG or PCI by maintaining the bed rest for more than 2 hours after the procedure. Angio-Seal seems most effective of current closure devices. There is less discomfort associated with early compared with late mobilization. Protamine reverse heparin's effect without the side effects of that regime.

There lacks a larger randomized study of the safety of mobilizing patients immediately after CAG and after PCI.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CAG or PCI performed via the femoral artery
  • No hematoma in the groin (> 5 cm in diameter)
  • Heparin reversed with protamine after PCI

Exclusion criteria

  • Oozing, bleeding or hematoma
  • Treatment with Integrilin, ReoPro, or Marevan
  • Heparin can not be reversed
  • The patient does not want to participate
  • Systolic blood pressure > 180 mm Hg after the procedure
  • BMI> 35 (can be modified if the groin can be assessed in an upright position)
  • Demented, unconscious patients who do not understand the information for participants.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,000 participants in 2 patient groups

Immediate mobilization
Experimental group
Description:
Immediate mobilization after coronary angiography or percutaneous coronary intervention
Treatment:
Other: Immediate mobilization
Two hours bedrest
Active Comparator group
Description:
Bedrest two hours after coronary angiography or percutaneous coronary intervention
Treatment:
Other: Two hours bedrest

Trial contacts and locations

1

Loading...

Central trial contact

Marianne W Noergaard, MVO; Jane Faerch, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems